Viz AAA vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (Viz AAA) is designed for the acute detection and triage of suspected Abdominal Aortic Aneurysm from CT angiography scans, focusing on accelerating diagnosis and care coordination for a specific vascular condition. In contrast, Tool B (IM007) specializes in the remote monitoring of cardiac implantable electronic devices, leveraging AI to streamline workflows, reduce false alerts, and predict heart failure risk for ongoing patient management. While both are FDA-cleared AI solutions in cardiology, their distinct applications—acute diagnostic imaging analysis versus chronic remote device monitoring—make them suitable for different clinical needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. IM007 is an FDA-cleared, AI-powered platform for remote cardiac monitoring, designed to aggregate data from cardiac implantable electronic devices (CIEDs) to streamline workflows and improve patient outcomes in cardiology and heart failure management.
Viz AAA uses artificial intelligence to automatically search for the presence of an abdominal aortic aneurysm from computed tomography angiography (CTA) scans. IM007 aggregates data from all cardiac implantable electronic devices (CIEDs), including those from Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort, for analysis.
Viz AAA's primary function is the AI-powered automatic detection of suspected AAA from CTA scans, automated triage, and prioritization of cases, designed to accelerate diagnosis and care coordination. IM007's primary functions include unified device data aggregation, AI-driven alert management to reduce false positives (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts), and smart workflow automation for billing, reporting, and scheduling, aiming to streamline workflows and improve patient outcomes.
Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm from CT angiography scans. IM007 includes an FDA-cleared AI for ICM ECG data analysis (ILR ECG Analyzer) and an FDA-cleared predictive AI for heart failure hospitalization risk (SignalHF).
Viz AAA is designed for integration into existing hospital workflows and provides a HIPAA-compliant communication platform for multidisciplinary teams. IM007 offers EHR integration capabilities through a bidirectional API and integration framework, alongside smart workflow automation for tasks such as billing, reporting, and scheduling.
Viz AAA is designed to support specialties such as Emergency Medicine, Radiology, and Vascular Surgery. IM007 is designed for Cardiology and Hospital Medicine.